Curr Opin Investig Drugs. 2008 Feb;9(2):210-25.

Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.

Source

Froedtert Hospital, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA. wpeppard@fmlh.edu

Abstract

Arpida Ltd, under license from Roche AG, is developing the diaminopyrimidine dihydrofolate reductase inhibitor iclaprim for the potential treatment of methicillin-resistant Staphylococcus aureus infections, including complicated skin and skin structure infections and hospital-acquired pneumonia. Phase III cSSSI clinical trials have been completed and an NDA filing process is ongoing. A phase II clinical trial for hospital-acquired pneumonia is ongoing.

PMID:: 18246524; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Related citations

Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. [Curr Opin Investig Drugs. 2008]
Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection.
Parish D, Scheinfeld N. Curr Opin Investig Drugs. 2008 Feb; 9(2):201-9.
Review Iclaprim. [Expert Opin Investig Drugs. 2007]
Review Iclaprim.
Kohlhoff SA, Sharma R. Expert Opin Investig Drugs. 2007 Sep; 16(9):1441-8.
Review Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections. [Ann Pharmacother. 2009]
Review Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections.
Sincak CA, Schmidt JM. Ann Pharmacother. 2009 Jun; 43(6):1107-14. Epub 2009 May 12.
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. [Bioorg Med Chem Lett. 2003]
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.
Schneider P, Hawser S, Islam K. Bioorg Med Chem Lett. 2003 Dec 1; 13(23):4217-21.
Review Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections. [Future Microbiol. 2009]
Review Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections.
Morgan A, Cofer C, Stevens DL. Future Microbiol. 2009 Mar; 4(2):131-44.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potentia...
Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.
Curr Opin Investig Drugs. 2008 Feb ;9(2):210-25.

PubMed
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity agai...
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Anticancer Drugs. 2007 Jan ;18(1):65-78.

PubMed
Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neut...
Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
J Virol. 2005 May ;79(10):6068-77.

PubMed
Quetiapine for mania due to traumatic brain injury.
Quetiapine for mania due to traumatic brain injury.
CNS Spectr. 2007 Oct ;12(10):764-9.

PubMed
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive propert...
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists.
J Nat Prod. 2010 Mar 26 ;73(3):306-12.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information